Advertisement
Screener

INSMED INC (INSM) Increase (Decrease) in Accounts Payable

2.8 / 5 stars · 68/120 Roast Me

INSMED INC Increase (Decrease) in Accounts Payable

INSMED INC (INSM) reported Increase (Decrease) in Accounts Payable of $44.59 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-20.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2025-02-20

  • INSMED INC increase (decrease) in accounts payable for the quarter ending 2022-06-30 was -$16.92M, a 285.64% decline year-over-year.
  • INSMED INC increase (decrease) in accounts payable for the quarter ending 2022-03-31 was $13.36M.
  • INSMED INC increase (decrease) in accounts payable for the quarter ending 2021-12-31 was $11.28M, a 45.53% decline year-over-year.
  • INSMED INC increase (decrease) in accounts payable for the quarter ending 2021-09-30 was -$7.70M.
  • INSMED INC increase (decrease) in accounts payable for fiscal 2024 was $44.59M, a 194.24% increase from fiscal 2023.
  • INSMED INC increase (decrease) in accounts payable for fiscal 2023 was $15.15M, a 69.70% decline from fiscal 2022.
  • INSMED INC increase (decrease) in accounts payable for fiscal 2022 was $50.01M.
  • INSMED INC increase (decrease) in accounts payable for fiscal 2021 was -$7.58M, a 125.40% decline from fiscal 2020.
Period endIncrease (Decrease) in Accounts Payable 3 monthIncrease (Decrease) in Accounts Payable 6 monthIncrease (Decrease) in Accounts Payable 9 monthIncrease (Decrease) in Accounts Payable 12 month
2024-12-31$44.59M
10-K · filed 2025-02-20
2023-12-31$15.15M
10-K · filed 2025-02-20
2022-12-31$50.01M
10-K · filed 2025-02-20
2022-06-30-$16.92M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$3.56M
10-Q · filed 2022-08-04
$7.72M
derived: sum of 3 quarters · filed 2024-02-22
$25.00K
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31$13.36M
10-Q · filed 2022-05-05
$24.64M
derived: sum of 2 quarters · filed 2024-02-22
$16.95M
derived: sum of 3 quarters · filed 2024-02-22
$26.06M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31$11.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$3.58M
derived: sum of 2 quarters · filed 2024-02-22
$12.70M
derived: sum of 3 quarters · filed 2024-02-22
-$7.58M
10-K · filed 2024-02-22
2021-09-30-$7.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28
$1.42M
derived: sum of 2 quarters · filed 2022-08-04
-$18.85M
10-Q · filed 2021-10-28
$1.85M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30$9.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$11.16M
10-Q · filed 2022-08-04
$9.55M
derived: sum of 3 quarters · filed 2023-02-23
$6.49M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31-$20.27M
10-Q · filed 2022-05-05
$432.00K
derived: sum of 2 quarters · filed 2023-02-23
-$2.62M
derived: sum of 3 quarters · filed 2023-02-23
$5.38M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$20.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$17.65M
derived: sum of 2 quarters · filed 2023-02-23
$25.66M
derived: sum of 3 quarters · filed 2023-02-23
$29.82M
10-K · filed 2023-02-23
2020-09-30-$3.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28
$4.95M
derived: sum of 2 quarters · filed 2021-10-28
$9.12M
10-Q · filed 2021-10-28
$2.74M
derived: sum of 4 quarters · filed 2022-02-17
2020-06-30$8.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$12.18M
10-Q · filed 2021-08-05
$5.80M
derived: sum of 3 quarters · filed 2022-02-17
$8.49M
derived: sum of 4 quarters · filed 2022-02-17
2020-03-31$4.17M
10-Q · filed 2021-05-06
-$2.21M
derived: sum of 2 quarters · filed 2022-02-17
$487.00K
derived: sum of 3 quarters · filed 2022-02-17
-$10.30M
derived: sum of 4 quarters · filed 2022-02-17
2019-12-31-$6.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17
-$3.68M
derived: sum of 2 quarters · filed 2022-02-17
-$14.46M
derived: sum of 3 quarters · filed 2022-02-17
-$4.97M
10-K · filed 2022-02-17
2019-09-30$2.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
-$8.09M
derived: sum of 2 quarters · filed 2020-10-29
$1.41M
10-Q · filed 2020-10-29
$2.74M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$10.78M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$1.28M
10-Q · filed 2020-08-06
$50.00K
derived: sum of 3 quarters · filed 2021-02-25
$605.00K
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$9.50M
10-Q · filed 2020-04-30
$10.83M
derived: sum of 2 quarters · filed 2021-02-25
$11.39M
derived: sum of 3 quarters · filed 2021-02-25
$14.20M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$1.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$1.89M
derived: sum of 2 quarters · filed 2021-02-25
$4.70M
derived: sum of 3 quarters · filed 2021-02-25
$3.87M
10-K · filed 2021-02-25
2018-09-30$555.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30
$3.36M
derived: sum of 2 quarters · filed 2019-10-30
$2.54M
10-Q · filed 2019-10-30
$7.06M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$2.81M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
$1.98M
10-Q · filed 2019-08-01
$6.51M
derived: sum of 3 quarters · filed 2020-02-25
$4.82M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31-$828.00K
10-Q · filed 2019-05-07
$3.70M
derived: sum of 2 quarters · filed 2020-02-25
$2.01M
derived: sum of 3 quarters · filed 2020-02-25
$4.80M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$4.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$2.84M
derived: sum of 2 quarters · filed 2020-02-25
$5.63M
derived: sum of 3 quarters · filed 2020-02-25
$3.60M
10-K · filed 2020-02-25
2017-09-30-$1.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30
$1.10M
derived: sum of 2 quarters · filed 2018-10-30
-$921.00K
10-Q · filed 2018-10-30
$1.49M
derived: sum of 4 quarters · filed 2019-02-22
2017-06-30$2.79M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
$767.00K
10-Q · filed 2018-08-02
$3.17M
derived: sum of 3 quarters · filed 2019-02-22
$2.31M
derived: sum of 4 quarters · filed 2019-02-22
2017-03-31-$2.03M
10-Q · filed 2018-05-02
$380.00K
derived: sum of 2 quarters · filed 2019-02-22
-$481.00K
derived: sum of 3 quarters · filed 2019-02-22
$214.00K
derived: sum of 4 quarters · filed 2019-02-22
2016-12-31$2.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
$1.54M
derived: sum of 2 quarters · filed 2019-02-22
$2.24M
derived: sum of 3 quarters · filed 2019-02-22
$2.77M
10-K · filed 2019-02-22
2016-09-30-$861.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
-$166.00K
derived: sum of 2 quarters · filed 2017-11-02
$361.00K
10-Q · filed 2017-11-02
-$2.76M
derived: sum of 4 quarters · filed 2018-02-23
2016-06-30$695.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
$1.22M
10-Q · filed 2017-08-03
-$1.90M
derived: sum of 3 quarters · filed 2018-02-23
$422.00K
derived: sum of 4 quarters · filed 2018-02-23
2016-03-31$527.00K
10-Q · filed 2017-05-03
-$2.59M
derived: sum of 2 quarters · filed 2018-02-23
-$273.00K
derived: sum of 3 quarters · filed 2018-02-23
$135.00K
derived: sum of 4 quarters · filed 2018-02-23
2015-12-31-$3.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
-$800.00K
derived: sum of 2 quarters · filed 2018-02-23
-$392.00K
derived: sum of 3 quarters · filed 2018-02-23
-$1.78M
10-K · filed 2018-02-23
2015-09-30$2.32M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$2.73M
derived: sum of 2 quarters · filed 2016-11-03
$1.34M
10-Q · filed 2016-11-03
$2.11M
derived: sum of 4 quarters · filed 2017-02-23
2015-06-30$408.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
-$981.00K
10-Q · filed 2016-08-04
-$215.00K
derived: sum of 3 quarters · filed 2017-02-23
-$1.31M
derived: sum of 4 quarters · filed 2017-02-23
2015-03-31-$1.39M
10-Q · filed 2016-05-05
-$623.00K
derived: sum of 2 quarters · filed 2017-02-23
-$1.72M
derived: sum of 3 quarters · filed 2017-02-23
-$1.97M
derived: sum of 4 quarters · filed 2017-02-23
2014-12-31$766.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
-$330.00K
derived: sum of 2 quarters · filed 2017-02-23
-$577.00K
derived: sum of 3 quarters · filed 2017-02-23
$3.31M
10-K · filed 2017-02-23
2014-09-30-$1.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
-$1.34M
derived: sum of 2 quarters · filed 2015-11-06
$2.55M
10-Q · filed 2015-11-06
$3.81M
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30-$247.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$3.64M
10-Q · filed 2015-08-06
$4.91M
derived: sum of 3 quarters · filed 2016-02-25
$1.71M
derived: sum of 4 quarters · filed 2016-02-25
2014-03-31$3.89M
10-Q · filed 2015-05-07
$5.16M
derived: sum of 2 quarters · filed 2016-02-25
$1.95M
derived: sum of 3 quarters · filed 2016-02-25
$1.63M
derived: sum of 4 quarters · filed 2016-02-25
2013-12-31$1.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25
-$1.94M
derived: sum of 2 quarters · filed 2016-02-25
-$2.25M
derived: sum of 3 quarters · filed 2016-02-25
-$1.13M
10-K · filed 2016-02-25
2013-09-30-$3.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
-$3.52M
derived: sum of 2 quarters · filed 2014-11-06
-$2.40M
10-Q · filed 2014-11-06
$1.68M
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30-$319.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06
$805.00K
10-Q · filed 2014-08-06
$4.88M
derived: sum of 3 quarters · filed 2015-02-27
$4.67M
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31$1.12M
10-Q · filed 2014-05-08
$5.20M
derived: sum of 2 quarters · filed 2015-02-27
$4.99M
derived: sum of 3 quarters · filed 2015-02-27
$5.30M
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31$4.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$3.86M
derived: sum of 2 quarters · filed 2015-02-27
$4.18M
derived: sum of 3 quarters · filed 2015-02-27
$4.73M
10-K · filed 2015-02-27
2012-09-30-$213.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05
$106.00K
derived: sum of 2 quarters · filed 2013-11-05
$651.00K
10-Q · filed 2013-11-05
$1.48M
derived: sum of 4 quarters · filed 2014-03-06
2012-06-30$319.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06
$864.00K
10-Q · filed 2013-08-06
$1.69M
derived: sum of 3 quarters · filed 2014-03-06
$1.28M
derived: sum of 4 quarters · filed 2014-03-06
2012-03-31$545.00K
10-Q · filed 2013-05-07
$1.38M
derived: sum of 2 quarters · filed 2014-03-06
$958.00K
derived: sum of 3 quarters · filed 2014-03-06
-$203.00K
derived: sum of 4 quarters · filed 2014-03-06
2011-12-31$830.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06
$413.00K
derived: sum of 2 quarters · filed 2014-03-06
-$748.00K
derived: sum of 3 quarters · filed 2014-03-06
$884.00K
10-K · filed 2014-03-06
2011-09-30-$417.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07
-$1.58M
derived: sum of 2 quarters · filed 2012-11-07
$54.00K
10-Q · filed 2012-11-07
-$2.81M
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30-$1.16M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07
$471.00K
10-Q · filed 2012-08-07
-$2.40M
derived: sum of 3 quarters · filed 2013-03-18
-$2.88M
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31$1.63M
10-Q · filed 2012-05-08
-$1.24M
derived: sum of 2 quarters · filed 2013-03-18
-$1.72M
derived: sum of 3 quarters · filed 2013-03-18
2010-12-31-$2.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
-$3.35M
derived: sum of 2 quarters · filed 2013-03-18
-$2.75M
10-K · filed 2013-03-18
2010-09-30-$481.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-09
$119.00K
10-Q · filed 2011-11-09
2010-06-30$600.00K
10-Q/A · filed 2011-08-08
2009-12-31-$85.00K
10-K · filed 2012-03-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Zoetis Inc. (ZTS)United States$29.045B11.38
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10